Your browser doesn't support javascript.
loading
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder.
Grimm, Simone; Keicher, Christian; Paret, Christian; Niedtfeld, Inga; Beckmann, Christian; Mennes, Maarten; Just, Stefan; Sharma, Vikas; Fuertig, René; Herich, Lena; Mack, Salome; Thamer, Claus; Schultheis, Christian; Weigand, Anne; Schmahl, Christian; Wunder, Andreas.
Affiliation
  • Grimm S; Medical School Berlin, Berlin, Germany; Department of Psychiatry, Charité, Campus Benjamin Franklin, Berlin, Germany. Electronic address: simone.grimm@medicalschool-berlin.de.
  • Keicher C; Charité Research Organisation GmbH, Berlin, Germany.
  • Paret C; Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
  • Niedtfeld I; Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
  • Beckmann C; SBGneuro Ltd., Oxford, UK.
  • Mennes M; SBGneuro Ltd., Oxford, UK.
  • Just S; Department of CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
  • Sharma V; TA CNS Retinopathies Emerging Areas Med, Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
  • Fuertig R; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
  • Herich L; Staburo GmbH, München, Germany.
  • Mack S; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
  • Thamer C; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
  • Schultheis C; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
  • Weigand A; Medical School Berlin, Berlin, Germany.
  • Schmahl C; Department of Psychosomatic Medicine and Psychotherapy, Central Institute of Mental Health Mannheim, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
  • Wunder A; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Eur Neuropsychopharmacol ; 65: 44-51, 2022 12.
Article de En | MEDLINE | ID: mdl-36343427
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trouble dépressif majeur / Canaux cationiques TRP Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Eur Neuropsychopharmacol Sujet du journal: PSICOFARMACOLOGIA Année: 2022 Type de document: Article Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trouble dépressif majeur / Canaux cationiques TRP Type d'étude: Clinical_trials Limites: Humans Langue: En Journal: Eur Neuropsychopharmacol Sujet du journal: PSICOFARMACOLOGIA Année: 2022 Type de document: Article Pays de publication: Pays-Bas